September 10, 2025Open Access

Evaluation of clinical scales among populations diagnosed with atopic dermatitis: A scoping review

View Full Paper

Ask AI

Bookmark

Authors

JXJoy H. XuUniversity of California, San Francisco SMS. MasoodStanford Medicine HDHarshdeep Dhaliwal

Discussion

Member takes

Implication

Scoping review highlights the effectiveness of clinician-based and patient-reported tools for atopic dermatitis, revealing underrepresentation of skin-of-colour cohorts.

Key Points

Clinician-based tools often underestimate atopic dermatitis severity in skin-of-colour populations, impacting diagnosis and treatment.
28 articles evaluated, with 24 focusing on clinician-rated scales like EASI and SCORAD, showing significant limitations in darker skin types.
Observational evaluations of patient-reported outcomes indicated a strong bias in prior tools, emphasizing the need for broader validation.
Future studies must address ethnic diversity and develop consensus-driven adaptations for reliable assessment across all skin types.

Cite This Study

Xu et al. (2025) studied this question.

synapsesocial.com/papers/68c23b8fb210217d647859a6 https://doi.org/10.1101/2025.09.02.25334962

View Full Paper

Ask AI

Bookmark

Implication

Scoping review highlights the effectiveness of clinician-based and patient-reported tools for atopic dermatitis, revealing underrepresentation of skin-of-colour cohorts.

Evaluation of clinical scales among populations diagnosed with atopic dermatitis: A scoping review

Discussion

Member takes

Implication

Key Points

Cite This Study

Evaluation of clinical scales among populations diagnosed with atopic dermatitis: A scoping review

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider